Diabetic Medicine

Announcement
pp. i-ii(1)

Physical activity consultation for people with Type 2 diabetes. Evidence and guidelines
pp. 809-816(8)
Authors: Kirk, A. F.; Barnett, J.; Mutrie, N.

Genetic variation within the APPL locus is not associated with metabolic or inflammatory traits in a healthy White population
pp. 817-822(6)
Authors: Staiger, H.; Machicao, F.; Machann, J.; Schick, F.; Kuulasmaa, T.; Laakso, M.; Fritsche, A.; Stefan, N.; Häring, H-U.

When is a technically successful peripheral angioplasty effective in preventing above-the-ankle amputation in diabetic patients with critical limb ischaemia?
pp. 823-829(7)
Authors: Faglia, E.; Clerici, G.; Clerissi, J.; Mantero, M.; Caminiti, M.; Quarantiello, A.; Curci, V.; Lupattelli, T.; Morabito, A.

Do simple questions about diet and physical activity help to identify those at risk of Type 2 diabetes?
pp. 830-835(6)
Authors: Simmons, R. K.; Harding, A-H.; Wareham, N. J.; Griffin, S. J.

Indications for insulin pump therapy in different age groups—an analysis of 1567 children and adolescents
pp. 836-842(7)
Authors: Kapellen, T. M.; Heidtmann, B.; Bachmann, J.; Ziegler, R.; Grabert, M.; Holl, R. W.

Association of erythrocyte indices with glycated haemoglobin in pre-menopausal women
pp. 843-847(5)
Authors: Koga, M.; Morita, S.; Saito, H.; Mukai, M.; Kasayama, S.

Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults
pp. 848-854(7)
Authors: Sung, K. C.; Rhee, E. J.

The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: The Cardiovascular Health Study
pp. 855-863(9)
Authors: Stein, P. K.; Barzilay, J. I.; Domitrovich, P. P.; Chaves, P. M.; Gottdiener, J. S.; Heckbert, S. R.; Kronmal, R. A.

Metabolic syndrome is not associated with markers of subclinical atherosclerosis, serum adiponectin and endogenous androgen concentrations in Japanese men with Type 2 diabetes
pp. 864-871(8)
Authors: Fukui, M.; Ose, H.; Kitagawa, Y.; Kamiuchi, K.; Nakayama, I.; Ohta, M.; Obayashi, H.; Yamasaki, M.; Hasegawa, G.; Yoshikawa, T.; Nakamura, N.

Prevalence of depression and diabetes: a population-based study from rural Bangladesh
pp. 872-877(6)
Authors: Asghar, S.; Hussain, A.; Ali, S. M. K.; Khan, A. K. A.; Magnusson, A.

Development and validation of the Diabetes Obstacles Questionnaire (DOQ) to assess obstacles in living with Type 2 diabetes
pp. 878-882(5)
Authors: Hearnshaw, H.; Wright, K.; Dale, J.; Sturt, J.; Vermeire, E.; van Royen, P.

The influence of health threat communication and personality traits on personal models of diabetes in newly diagnosed diabetic patients
pp. 883-891(9)
Authors: Lawson, V. L.; Bundy, C.; Harvey, J. N.

The association of life course socio-economic position with diagnosis, treatment, control and survival of women with diabetes: findings from the British Women's Heart and Health Study
pp. 892-900(9)
Authors: Lawlor, D. A.; Patel, R.; Fraser, A.; Smith, G. Davey; Ebrahim, S.

Evidence-based medicine for diabetes educators: a pilot study
pp. 901-905(5)
Authors: Meyer, G.; Köpke, S.; Lenz, M.; Kasper, J.; Mühlhauser, I.

Effect of raloxifene—a selective oestrogen receptor modulator—on kidney function in post-menopausal women with Type 2 diabetes: results from a randomized, placebo-controlled pilot trial
pp. 906-910(5)
Authors: Hadjadj, S.; Gourdy, P.; Zaoui, P.; Guerci, B.; Roudaut, N.; Gautier, J. F.; Chabin, M.; Mauco, G.; Ragot, S.

Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in Type 2 diabetic subjects
pp. 911-915(5)
Authors: Knudsen, S. T.; Jeppesen, P.; Frederiksen, C. A.; Andersen, N. H.; Bek, T.; Ingerslev, J.; Mogensen, C. E.; Poulsen, P. L.

Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3)
pp. 916-919(4)
Authors: Locatelli, M.; Buzzetti, R.; Galgani, A.; Montemari, A. L.; Khazrai, M.; Petrone, A.; Visalli, N.; Meschi, F.; Minicucci, L.; Lorini, R.; Cristaldi, A.; Valorani, M. G.; Bottazzo, G. F.; Pozzilli, P.

Major increase in Type 1 diabetes—no support for the Accelerator Hypothesis
pp. 920-923(4)
Authors: O'Connell, M. A.; Donath, S.; Cameron, F. J.

We should continue talking about screening for Type 2 diabetes
pp. 924-924(1)
Authors: Echouffo-Tcheugui, J. B.; Sargeant, L. A.; Griffin, S. J.

Authors' response
pp. 924-925(2)
Authors: Stephens, J. W.; Williams, R.

The sex ratios of offspring of diabetic parents
pp. 925-926(2)
Authors: Cypryk, K.; Pertynska-Marczewska, M.; Wender-Ozegowska, E.; Lewinski, A.

Author's response
pp. 926-926(1)
Author: James, W. H.

Association of circulating endothelial progenitor cell growth in patients with Type 2 diabetes with type of glucose-lowering treatment
pp. 926-927(2)
Authors: Sourij, H.; Strunk, D.; Rohde, E.; Wascher, T. C.

Diary dates
pp. 928-928(1)